Ibsrela (tenapanor) and Linzess (linaclotide) are commonly prescribed treatments for irritable bowel syndrome with ...

SB 1211, which passed the legislature earlier this session, permits the sale or purchase of ivermectin "suitable for human ...

Ibsrela (tenapanor) can cause side effects such as diarrhea, bloating, gas, and dizziness, among others. Side effects can ...

These scripts for confident client conversations are compassionate and provide options to help ease pet owners’ concerns ...

PFE's decision to scrap the development of danuglipron comes after a study participant develops potential drug-induced liver injury.

This release has been authorised by the directors of Immuron Limited. Steven Lydeamore Chief Executive Officer ...

Nutritional Fundamentals for Health (NFH) has recalled over 17,000 bottles of iron supplements due to non-compliance with ...

To make it easier to remember, Clark recommends pairing your B12 supplement with an existing habit, like brushing your teeth ...

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.

diarrhea, and decreased appetite. Across all studies of Zunveyl, GI adverse events were reported in less than 2% of patients. Zunveyl is supplied as 5mg, 10mg, and 15mg delayed-release tablets ...

(Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today ...